Comments
Loading...
Number of Stock Holdings
30
Number of Bond Holdings
-
Total Holdings
33
Number of ETFs
-
Invesco Biotechnology & Genome ETF (ARCA:PBE), Top Holdings
Invesco Biotechnology & Genome ETF (ARCA: PBE)
| Ticker | Name | Share % | |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 5.48% | |
| ILMN | Illumina Inc - Common | 5.37% | |
| INCY | Incyte Corp. | 5.32% | |
| BMRN | Biomarin Pharmaceutical Inc. | 5.09% | |
| VRTX | Vertex Pharmaceuticals Inc | 5.05% | |
| AMGN | Amgen Inc. | 4.98% | |
| REGN | Regeneron Pharmaceuticals, Inc. | 4.97% | |
| NBIX | Neurocrine Biosciences Inc | 4.51% | |
| IONS | Ionis Pharmaceuticals Inc | 3.24% | |
| HALO | Halozyme Therapeutics Inc | 3.17% | |
FAQ
How has PBE ETF performed?
The PBE ETF is currently trading at $65.50, which represents a 0.01% change. Over the past 52 weeks, the ETF has traded as high as $72.84 and as low as $59.32.
What is the expense ratio for PBE?
The expense ratio of PBE is NA%. This represents the annual fee that all funds or ETFs charge their shareholders.
What is the Assets Under Management (AUM) for PBE?
The total Assets Under Management (AUM) for PBE is 264.20M. This represents the total market value of the assets managed by the ETF.
What is the investment style for PBE?
PBE follows a Mid Cap Growth investment style.
What are the top holdings for PBE?
The top holdings of PBE include: GILD (5.48%), ILMN (5.37%), INCY (5.32%), BMRN (5.09%), VRTX (5.05%). These represent the largest positions in the ETF's portfolio.
What is the average daily trading volume for PBE?
Average daily volume data for PBE is currently not available.